---
title: "Novavax Inc. Stock Underperforms Wednesday When Compared To Competitors"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/293524237.md"
description: "Novavax Inc. (NVAX) shares fell 2.04% to $7.91 on Wednesday, underperforming competitors like Johnson & Johnson and Merck during a generally weak market session. The stock closed 33.92% below its 52-week high of $11.97. Trading volume was notably lower than the 50-day average."
datetime: "2026-07-22T21:27:04.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/293524237.md)
  - [en](https://longbridge.com/en/news/293524237.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/293524237.md)
generator: "portal-rs"
---

# Novavax Inc. Stock Underperforms Wednesday When Compared To Competitors

This article was automatically generated by MarketWatch using technology from Automated Insights.

Shares of Novavax Inc. (NVAX) slipped 2.04% to $7.91 Wednesday, on what proved to be an all-around poor trading session for the stock market, with the NASDAQ Composite Index falling 0.57% to 25,690.90 and Dow Jones Industrial Average falling 0.01% to 52,218.58.

Novavax Inc. closed 33.92% short of its 52-week high of $11.97, which the company reached on February 26th.

The stock underperformed when compared to some of its competitors Wednesday, as Johnson & Johnson (JNJ) rose 2.00% to $255.63, Pfizer Inc. (PFE) fell 0.48% to $24.82, and Merck & Co. Inc. (MRK) rose 0.96% to $127.47.

Trading volume (2.6 M) remained 2.2 million below its 50-day average volume of 4.8 M.

Data source: Dow Jones Market Data, FactSet. Data compiled July 22, 2026.

This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.

(END) Dow Jones Newswires

07-22-26 1727ET

### Related Stocks

- [NVAX.US](https://longbridge.com/en/quote/NVAX.US.md)
- [.IXIC.US](https://longbridge.com/en/quote/.IXIC.US.md)
- [.DJI.US](https://longbridge.com/en/quote/.DJI.US.md)
- [JNJ.US](https://longbridge.com/en/quote/JNJ.US.md)
- [PFE.US](https://longbridge.com/en/quote/PFE.US.md)
- [MRK.US](https://longbridge.com/en/quote/MRK.US.md)

## Related News & Research

- [Novavax to Participate in September Investor Conferences | NVAX Stock News](https://longbridge.com/en/news/297830700.md)
- [Novavax Inc. Stock Outperforms Competitors On Strong Trading Day](https://longbridge.com/en/news/297833178.md)
- [Novavax Stock Rises Despite No Confirmed News Behind the Matrix-M Rumor](https://longbridge.com/en/news/297790663.md)
- [Novavax Partners Receive Approvals For Nuvaxovid Formulation To Target Covid Variant](https://longbridge.com/en/news/297333166.md)
- [How BioMarin’s Navepegritide Settlement and Royalty Deal with Ascendis Could Shape BioMarin (BMRN) Investors](https://longbridge.com/en/news/297761649.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**